New genetic drivers in hemorrhagic hereditary telangiectasia-Reference-Cited by-同舟云学术

New genetic drivers in hemorrhagic hereditary telangiectasia

Published:2024-01 Issue: Volume:119 Page:99-108
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Cerdà Pau^ORCID,Castillo Sandra D.^ORCID,Aguilera Cinthia,Iriarte Adriana,Rocamora José Luis,Larrinaga Ane M.,Viñals Francesc,Graupera Mariona,Riera-Mestre Antoni^ORCID

Funder

Ministerio de Ciencia e Innovación

European Regional Development Fund

'la Caixa' Foundation

Fundación La Caixa

España Ministerio de Ciencia e Innovación

PTEN Research

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Internal Medicine

Reference67 articles.

1. The portal for rare diseases and orphan drugs. https://www.orpha.net/consor/cgi-bin/index.php.324 Accessed on 13 November 2022.

2. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia;Braverman;J Invest Dermatol,1990

3. Hereditary haemorrhagic telangiectasia: a clinical analysis;Porteous;J Med Genet,1992

4. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome);Shovlin;Am J Med Genet,2000

5. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia;Faughnan;Ann Intern Med,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pioneering the future: CRISPR-Cas9 gene therapy for hereditary hemorrhagic telangiectasia. Author's reply;European Journal of Internal Medicine;2024-09

2. Pioneering the future: CRISPR-Cas9 gene therapy for hereditary hemorrhagic telangiectasia;European Journal of Internal Medicine;2024-09

3. Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT);Cell & Bioscience;2024-05-22

4. Unveiling Endoglin non canonical regulation: spotlight on the new role of the uPAR pathway;2024-01-30